National Cancer Institute; Notice of Closed Meeting, 41032 [06-6291]

Download as PDF 41032 Federal Register / Vol. 71, No. 138 / Wednesday, July 19, 2006 / Notices collaborative research activities. The study will involve interviewing former APRC-funded researchers. The evaluation results will provide DCB with the information to make quality improvements to the APRC program and enhance program performance in generating significant outcomes. It will also strengthen our understanding of the value of collaborative and interdisciplinary research and inform Estimated Number of Responses per Respondent: 1; Average Burden Hours per Response: .5; and Estimated Total Annual Burden Hours Requested: 125. The annualized cost to respondents is estimated at: $4034. There are no Capital Costs, Operating Costs, and/or Maintenance Costs to report. NCI’s approach to supporting and encouraging scientific collaboration among researchers from multiple disciplines in the future. Frequency of Response: One time. Affected Public: Individuals; scientific and research communities. Type of Respondents: Researchers. The annual reporting burden is as follows: Estimated Number of Respondents: 250; Estimated annual No. of respondents Estimated No. of responses per respondents Average burden hours per response Estimated total annual burden hours requested Researcher ...................................................................................... sroberts on PROD1PC70 with NOTICES Type of respondents 250 1 0.5 125 Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Kelly Kim, Program Administrator, DNA and Chromosome Aberrations Branch, DCB, NCI, NIH, 6130 Executive Blvd, Room 5025, Rockville, MD 20892, or call nontoll-free number 301–496–5473 or email your request, including your address to: kimke@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. VerDate Aug<31>2005 18:28 Jul 18, 2006 Jkt 208001 Dated: July 12, 2006. Rachelle Ragland Greene, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. E6–11382 Filed 7–18–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, SBIR Topic 196 Antibody Array for Cancer Detection—Phase II. Date: August 17, 2006. Time: 12:01 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: NIH Events Management, Executive Plaza North, 6130 Executive Boulevard, Conference Room C, Rockville, MD 20862, (Telephone Conference Call). Contact Person: Michael B. Small, PhD, Scientific Review Administrator, Research Programs Review Branch, PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8127, Bethesda, MD 20892–8328, 301–402–0996, smallm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower, 93.399, Cancer Control, National Institutes of Health, HHS) Dated: July 12, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–6291 Filed 7–18–06; 8:45 am] BILLING CODE 4410–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\19JYN1.SGM 19JYN1

Agencies

[Federal Register Volume 71, Number 138 (Wednesday, July 19, 2006)]
[Notices]
[Page 41032]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6291]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: National Cancer Institute Special Emphasis 
Panel, SBIR Topic 196 Antibody Array for Cancer Detection--Phase II.
    Date: August 17, 2006.
    Time: 12:01 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: NIH Events Management, Executive Plaza North, 6130 Executive 
Boulevard, Conference Room C, Rockville, MD 20862, (Telephone 
Conference Call).
    Contact Person: Michael B. Small, PhD, Scientific Review 
Administrator, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of Health, 
6116 Executive Blvd., Room 8127, Bethesda, MD 20892-8328, 301-402-0996, 
smallm@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower, 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: July 12, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-6291 Filed 7-18-06; 8:45 am]
BILLING CODE 4410-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.